Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis C Viral”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT01833845
What this trial is testing

Efficacy, Safety and Tolerability of Ribavirin Monotherapy Followed by Combined Treatment With Ribavirin and Hydroxychloroquine in Patients Infected With Hepatitis C

Who this might be right for
Hepatitis C
BioLineRx, Ltd. 4
Testing effectiveness (Phase 2)WithdrawnNCT00051077
What this trial is testing

Treatment of Hepatitis in Patients Who Are Triple-Infected With HIV, Hepatitis B Virus (HBV), and Hepatitis C Virus (HCV)

Who this might be right for
HIV InfectionsHepatitis BHepatitis C
National Institute of Allergy and Infectious Diseases (NIAID)
Large-scale testing (Phase 3)Study completedNCT02640157
What this trial is testing

A Study Comparing Efficacy and Safety of ABT-493/ABT-530 to Sofosbuvir Dosed With Daclatasvir in Adults With HCV Genotype 3 Infection

Who this might be right for
Chronic Hepatitis CHepatitis C VirusGenotype 3 Hepatitis C Virus
AbbVie 506
Large-scale testing (Phase 3)Study completedNCT02319031
What this trial is testing

Safety and Efficacy Study of the Combination Daclatasvir (60 mg), Sofosbuvir (400 mg) and Ribavirin (Weight-based Dosing) for 12 or 16 Weeks in Subjects With Genotype 3 Chronic HCV Infection With or Without Prior Treatment Experience and Advanced Fibrosis or Compensated Cirrhosis

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 53
Large-scale testing (Phase 3)Study completedNCT02201953
What this trial is testing

Comparison of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks With Sofosbuvir and Ribavirin for 24 Weeks in Adults With Chronic Genotype 3 HCV Infection

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 558
Not applicableActive Not RecruitingNCT04701437
What this trial is testing

Advanced Care Coordination and Enhanced Linkage and Retention Among Transitional Re-Entrants

Who this might be right for
Hepatitis C
Montefiore Medical Center 80
Large-scale testing (Phase 3)Study completedNCT01197157
What this trial is testing

Study of the Impact of Nitazoxanide on Chronic Hepatitis Patients

Who this might be right for
Hepatitis C
National Liver Institute, Egypt 200
Testing effectiveness (Phase 2)Study completedNCT03819322
What this trial is testing

The Use of Hepatitis C Positive Livers in Hepatitis C Negative Liver Transplant Recipients

Who this might be right for
Liver TransplantHepatitis C
Fernanda P Silveira, MD, MS 5
Not applicableStudy completedNCT00710801
What this trial is testing

Assessment of Biomarkers for Recurrent HCV Infection Post-liver Transplantation

Who this might be right for
Hepatitis C Virus
University of Alberta 40
Testing effectiveness (Phase 2)Study completedNCT00807001
What this trial is testing

Double-Blind, Dose-Escalation Study of IDX184 in Chronic Hepatitis C Treatment-Naïve Subjects

Who this might be right for
Chronic Hepatitis C (HCV)
Merck Sharp & Dohme LLC 41
Post-approval studies (Phase 4)Study completedNCT03050905
What this trial is testing

Proof of Concept Study To Evaluate the Efficacy and Justification Of OBV/PTV/r and DSV In Adults With Chronic Hepatitis C Virus Genotype 2K/1B

Who this might be right for
HCV Coinfection
HaEmek Medical Center, Israel 7
Large-scale testing (Phase 3)Ended earlyNCT02600351
What this trial is testing

Efficacy and Safety of Ledipasvir/Sofosbuvir, With or Without Ribavirin, in HCV Infected Participants Who Have Failed Prior Treatment With Sofosbuvir-based Therapies

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 87
Not applicableStudy completedNCT04062253
What this trial is testing

Addressing the Cascade of Care in Vulnerable Populations With Poor Access to Healthcare in Madrid

Who this might be right for
HCV InfectionHIV InfectionsDrug Use+2 more
Hospital Universitario Infanta Leonor 2,001
Not applicableUnknownNCT03887637
What this trial is testing

Real-world Effectiveness and Safety of Treatment With DAAs in Patients With CHC(Chronic Hepatitis C)

Who this might be right for
Chronic Hepatitis C
Third Affiliated Hospital, Sun Yat-Sen University 180
Not applicableStudy completedNCT03413696
What this trial is testing

Effects of Health Literacy and HCV Knowledge on HCV Treatment Willingness in HIV-coinfected Patients

Who this might be right for
Hepatitis CHepatitis C, ChronicHIV/AIDS
University of California, San Diego 150
Testing effectiveness (Phase 2)Study completedNCT01724086
What this trial is testing

Evaluate the Safety, Tolerability, and Effectiveness of a 12-Week Combination Therapy of TMC647055 and TMC435 With and Without GSK23336805 With a Pharmacokinetic Enhancer With and Without Ribavirin in Patients Infected With Chronic Genotype 1 Hepatitis C Virus

Who this might be right for
Chronic Hepatitis C
Janssen R&D Ireland 90
Early research (Phase 1)Study completedNCT00372983
What this trial is testing

Safety and PK Study of NOV-205 to Treat Chronic HCV Who Fail Standard Therapy

Who this might be right for
Hepatitis C
Cellectar Biosciences, Inc. 30
Early research (Phase 1)Study completedNCT00996879
What this trial is testing

Study to Assess the Effect of BMS-791325 on the Pharmacokinetics of Midazolam in Healthy Subjects

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 48
Not applicableUnknownNCT02687061
What this trial is testing

Chronic Hepatitis B and C Recall Northern Holland

Who this might be right for
Hepatitis BHepatitis C
Stichting MDL Holland-Noord 300
Not applicableStudy completedNCT02006823
What this trial is testing

Patient Self-management and Gene Guided Therapy for Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
Duke University 20
Next Page